Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
Aging and multiple sclerosis.
Lateral ventricular cerebrospinal fluid diffusivity as a potential neuroimaging marker of brain temperature in multiple sclerosis: a hypothesis and implications.
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Methods and measures: what's new for MS?
Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
Mapi Pharma granted United States patent covering the process for the preparation of fingolimod for multiple sclerosis
Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Physician-patient communication skills: e-tools.
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).
[Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Oral BG-12 in multiple sclerosis.
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
Multiple sclerosis and oral health--an update.
The nervous system's potential role in multiple sclerosis associated bone loss.

Pages